MTS Health Partners

Pear Ther­a­peu­tics explor­ing sale, oth­er ‘strate­gic alter­na­tives’ (Mobi­Health News):

Pre­scrip­tion dig­i­tal ther­a­peu­tics com­pa­ny Pear Ther­a­peu­tics is explor­ing “strate­gic alter­na­tives,” includ­ing a pos­si­ble com­pa­ny sale, merg­er or acquisition.

In a press release, the com­pa­ny said it hired a finan­cial advi­sor to look into actions that could “max­i­mize share­hold­er val­ue.” That includes a poten­tial sale, M&A, divesti­ture of assets, licens­ing or oth­er strate­gic trans­ac­tions. It may also seek addi­tion­al financ­ing. [Read more…] about Pear Ther­a­peu­tics los­es 97% of its mar­ket cap­i­tal­iza­tion since 2021, explores strate­gic alternatives